On paper, things should be looking up for Japan’s pharmaceutical wholesalers. Industry expectations are mounting that the average gap between NHI and market prices will narrow further in FY2026 from the previous year’s record low of 4.8%.A shrinking gap should…
HOME > BUSINESS
BUSINESS
- Takeda Clinches Key US Clearance for Shire Takeover
July 10, 2018
- Nichi-Iko Ties Up with Sunward for Malaysia, Singapore Biz
July 10, 2018
- No Major Damage for Drug Makers, Wholesaler Logistics: West Japan Downpours
July 10, 2018
- Ethical Drug Sales Up 2.6% in May: Crecon
July 9, 2018
- Eisai/Biogen Say Alzheimer’s Candidate BAN2401 Delivered Positive Data at 18 Month Analysis
July 9, 2018
- New Takeda Global Headquarters Designed for LGBT Inclusion
July 9, 2018
- Shionogi Regains Exclusive US Rights to Symproic, Seeking New Partner
July 9, 2018
- No Drug Breaks 100 Billion Yen Mark in FY2017 Japan Sales Ranking: Jiho Tally
July 6, 2018
- Use of Digital Health Apps Could Reduce Medical Expenditure by 339 Billion Yen Annually: IQVIA
July 6, 2018
- Sumitomo Dainippon Files Thiotepa for Conditioning Regimen Prior to Autologous HSCT in Pediatric Solid Tumors
July 5, 2018
- Pfizer Wringing Hands over PMP Eligibility for Lorlatinib; It Might Earn 1st Conditional OK, but It’s “4th” ALK Inhibitor
July 5, 2018
- Meiji Holdings Makes Kaketsuken’s Successor Company Its Consolidated Subsidiary
July 4, 2018
- Single-Dose Flu Drug Xofluza Filed in Taiwan: Shionogi
July 3, 2018
- Takeda Celebrates Grand Opening for New Global Headquarters
July 3, 2018
- JCR Launches PIII Study of Growject for SHOX Deficiency
July 3, 2018
- Sawai President Shows Eagerness to “Take Over” To-Be-Withdrawn LLPs
July 2, 2018
- With Focus on CGRP, Development of New Generation of Preventive Treatments for Migraines Heating Up
July 2, 2018
- Baxalta Appeals to IP High Court in Hemlibra Patent Lawsuit against Chugai
July 2, 2018
- Weber Earns 1.2 Billion Yen in FY2017, Logging Western-Level Pay Ratio
June 29, 2018
- Grilled by Shareholders, Takeda CEO Seeks Understanding for Shire Deal
June 29, 2018
ページ
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
As Japan’s budget season draws near, the Ministry of Finance (MOF) has renewed its push for a full-scale “off-year” drug…
Japan will trim the NHI price of Eli Lilly Japan’s Alzheimer’s treatment Kisunla (donanemab) by 3.93% under the cost-effectiveness assessment…
Japan is set to add 16 new drugs to its NHI reimbursement price list on November 13, including a subcutaneous…
Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…